ABBOTT LABORATORIES — Director's Dealing 2020

Apr 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-04-21

Reporting Person: Funck Robert E (Executive Vice President & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-21	Common shares without par value	M	23700	$34.94	Acquired	193072	Direct
2020-04-21	Common shares without par value	M	13000	$39.12	Acquired	206072	Direct
2020-04-21	Common shares without par value	F	23855	$98	Disposed	182217	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-21	Option (right to buy)	$34.94	M	23700	Disposed	2023-02-14	Common shares (23700)	Direct
2020-04-21	Option (right to buy)	$39.12	M	13000	Disposed	2024-02-20	Common shares (13000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17570	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 21, 2020.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.